Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€65.60

€65.60

0.630%
0.41
0.630%
€80.72
 
19:40 / Tradegate WKN: 859034 / Symbol: CVS / Name: CVS Health / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

CVS Health Corp. Stock

The CVS Health Corp. stock is trending slightly upwards today, with an increase of €0.41 (0.630%) compared to yesterday's price.
With 24 Buy predictions and not a single Sell prediction CVS Health Corp. is an absolute favorite of our community.
With a target price of 80 € there is a positive potential of 21.95% for CVS Health Corp. compared to the current price of 65.6 €.
So far the community has only identified positive things for CVS Health Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

CVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.

Pros and Cons of CVS Health Corp. in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of CVS Health Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
CVS Health Corp. 0.630% 0.308% -8.467% -6.093% -9.003% 2.921% 38.496%
Cardinal Health Inc. 1.200% 0.363% -0.688% 37.476% 10.622% 94.529% 142.062%
AmerisourceBergen Corp. -0.960% 1.502% 1.249% 46.082% 21.195% 124.070% 247.870%
McKesson Corp. 0.140% -0.041% 0.062% 48.116% 17.705% 202.295% 382.858%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-31

In general, the financials of CVS Health, a major player in the Food & Drug Retailing industry, appear to be stable and relatively strong. The company has shown a steady growth in total assets and revenues over the past few years. However, it is crucial to dig deeper into the financial statements to identify the underlying strengths and potential areas of concern for the company.

Growth in Total Assets and Revenues: CVS Health's total assets and revenues have experienced positive growth from 2020 to 2022. In 2020, the company's total assets were at €230.71 billion, and total revenues were at €268.71 billion. By 2022, these numbers increased to $228.28 billion and $322.47 billion, respectively. This indicates that CVS is continuously expanding its business operations and generating higher sales.

Increasing Gross Profit: CVS Health's gross profit has also seen consistent growth from €49.05 billion in 2020 to $54.29 billion in 2022. This reveals the company's ability to maintain its cost of revenue and increase overall profitability from its core operations.

Comments

Prediction Buy
Perf. (%) -2.24%
Target price 80.832
Change
Ends at 10.04.25

CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $87.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -5.19%
Target price 80.005
Change
Ends at 04.04.25

CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $87.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -8.40%
Target price 86.442
Change
Ends at 18.03.25

CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Piper Sandler from $93.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
Show more